Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Farrukh T. Awan

University of Texas Southwestern Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Articles (12)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2022

Collaborators (11)

Somedeb Ball

Vanderbilt University Medical Center

UNITED STATES

View details

Didier Blaise

Professor of Medicine

Aix-Marseille University

FRANCE

View details

Mehdi Hamadani

UNITED STATES

View details

Talha Badar

Leukemia Attending

Mayo Clinic Florida

UNITED STATES

View details

LaQuisa Hill

Associate Professor

Baylor College of Medicine

UNITED STATES

View details

Veronika Bachanova

Faculty, Professor

University of Minnesota

UNITED STATES

View details

Emanuele Angelucci

Hematology and Transpalnt Center Head

Ospedale Policlinico San Martino

ITALY

View details

Saad Kenderian

Mayo Clinic

UNITED STATES

View details

Ambuj Kumar

University of South Florida

UNITED STATES

View details

Soyoung Kim

Associate Professor

Medical College of Wisconsin

UNITED STATES

View details

Deborah Stephens

Assistant Professor

Huntsman Cancer Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Farrukh T. Awan

Research Interests

Explore related searches

Articles (12)

Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed/refractory del(17p) chronic lymphocytic leukaemia/small lymphocytic lymphoma

Outcomes of Hematopoietic Cell Transplantation in Patients with Plasmablastic Lymphoma

Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma

Pharmacologic activity, safety, and preliminary efficacy of GEN3009, a CD37-targeting DuoHexaBody, in relapsed or refractory B-cell non-Hodgkin’s lymphoma

Final phase 2 study results of acalabrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia

Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell Lymphoma.

Outcomes of Allogeneic HCT in Hodgkin Lymphoma in the Era of Checkpoint Inhibitors: A Joint CIBMTR and EBMT Analysis.

Clinical Practice Recommendations on the Role Of Allogeneic Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Patients With Chronic Lymphocytic Leukemia on Behalf of the American Society for Transplantation and Cellular Therapy

New Comorbidity Index Associated with Survival After Chimeric Antigen Receptor T Cell Therapy for Large B-Cell Lymphoma

Autologous Transplant or CAR‐T as Consolidation Options in MYC Rearranged Large B‐Cell Lymphoma Patients in Remission After Salvage Treatments

Cardiotoxicity of BTK inhibitors: ibrutinib and beyond

Collaborators (11)

Somedeb Ball

Didier Blaise

Mehdi Hamadani

Talha Badar

LaQuisa Hill

Veronika Bachanova

Emanuele Angelucci

Saad Kenderian

Ambuj Kumar

Soyoung Kim

Deborah Stephens

Make your next move.